Nexdigm Explores Global Interest in Geographic Diversification of Supply Chains - Senior Government Officials Spotlight Investment in the US-India Corridor
Against the backdrop of a projected multi-billion dollar spend on India's healthcare infrastructure by 2022, and an expected 17-19% CAGR for the next five years, American healthcare companies are setting their sights on investing in India. In the virtual event organized by Nexdigm (SKP) with support from the Consulate General of India, Chicago, Senior Indian Government Officials made compelling arguments for Foreign Direct Investment (FDI) in India.
In his remarks, honorable Mr. Arora, commented, “One of the reasons to select India is the educated workforce; the human resource development in medical and technical fields as well as the Research and Development available in this country is internationally competitive. These factors can add tremendous efficiencies to any business.”
As was aptly explained by honorable Mr. Kumar, “The pandemic has invited great collaboration between India and the USA, with multiple companies and agencies working together to fight COVID-19. The government has announced multiple subsidies, including allowing 100% Foreign Direct Investment in healthcare, which will augur well for the growth of the healthcare sector in India.”
The virtual event was organized by Nexdigm (SKP) with support from the Consulate General of India, Chicago. Also discussed was that a number of healthcare companies in the USA are setting their sights on investing in India. The session also highlighted the strong relations between the healthcare sectors of India and the USA, with a large number of US-based players, including Pfizer, Abbott, among others, already present in India. The long-standing collaboration between the Center for Disease Control and Prevention (USA), the National Institute of Health (USA), and the Indian Council of Medical Research was credited for supporting past and future FDI.
Mr. Kumar also highlighted India’s role in the fight against the pandemic with examples of cross-national collaboration to develop a vaccine. This includes the recently announced international partnership of the Serum Institute of India, as well as Bharat Biotech’s partnership with the University of Wisconsin-Madison.
The supply-side shocks associated with the COVID-19 pandemic have highlighted the business risks due to the concentration of supply from a single source. In international discussions, India has emerged as one of the most attractive FDI destinations, capable of hosting global organizations that are revisiting their manufacturing strategy, trying to hedge their sourcing and production.
With an existing, qualified workforce, India provides an edge for the set up of new investments and ventures. Substantial subsidies are being offered by the central and the state governments to help businesses jump-start their operations in India. These are further backed by conducive intellectual property laws, which are especially important for healthcare players.
Honorable Jyoti Arora highlighted the Electronics manufacturing industry, which has been a focus area for the Indian government and has seen 25% year-on-year growth over the last four years. The three major incentives introduced were notified by the Ministry of Electronics and IT (MietY) on April 1, and have a total outlay of INR 50,000 crore (USD 6.6 billion). These will be beneficial in building a strong ecosystem for pharma and medical devices. States are expected to introduce geo-tagging facilities for their regions soon, to help investors identify geographies for their investment.
Poised to be the world’s third-largest economy by 2030, India offers a stable financial, political, and judicial environment so that businesses can count on scalability and growth. In recent times, Walmart invested over USD 16 billion through Flipkart, Amazon invested USD 6.5 billion, and Facebook invested USD 5.7 billion in the region.
The government’s announcement of the simplification of the corporate tax regime, resulting in an effective 15% tax rate for new manufacturing setups, has enhanced India’s competitiveness as an Asian investment destination.
The pro-business attitude is echoed at the state level of governance. While states like Maharashtra and Gujarat have always been at the forefront of incentivizing investment, today, territories like Uttar Pradesh, have also introduced reforms to attract FDI.
India’s investment potential, as the world’s largest democracy, with a huge customer base, and a growing middle class is of interest to the current US administration. India’s large English-speaking populace and intellectual property laws provide a definite advantage for American investors. It is not surprising then that many multinational businesses have invested resources in cultural training about India.
Nexdigm is an employee-owned, independent, global business advisory organization serving clients from more than 50 countries. Harnessing multifunctional and digital capabilities across Business Consulting, Business Services, and Professional Services, they provide their customers, both listed and privately held firms, with integrated solutions to navigate complex challenges. Nexdigm resonates their plunge into a new paradigm of business; it is a commitment to Think Next. For more information, please visit www.nexdigm.com and connect with the team on ThinkNext@nexdigm.com, Facebook, Twitter, and LinkedIn.
India's healthcare outlook:
https://www.skpgroup.com/data/resource/indias_national_healthcare_protection_scheme_.pdf Webinar details: https://www.youtube.com/watch?v=XDpRlmd-Z3E
Incentives for the Electronics industry (MeitY) https://bit.ly/3d8XxwI
E-commerce investments in India: https://bloom.bg/37JF5tG
India's Corporate Tax rate: https://bit.ly/2AAJWRT